PAPR Supply for COVID-19 Frontline Response in the Philippines
How a Powered Air-Purifying Respirator (PAPR) programme, delivered through local distribution partner Biosite Medical Systems Inc., supported healthcare workers during the Philippines COVID-19 emergency response.
- PAPR units were supplied to frontline healthcare workers in the Philippines during the COVID-19 response.
- Distribution was handled through Biosite Medical Systems Inc., an ISO 9001:2015-certified medical device trader.
- Units feature HEPA filtration, a full-face anti-fog visor, and battery runtime suited to extended shifts.
- Several facilities continue using the same PAPR line for MDR-TB wards and other high-containment procedures.
During the COVID-19 pandemic, hospitals across the Philippines faced a sustained shortage of reliable respiratory protection for staff working in high-exposure environments. This case study covers how a PAPR supply programme was delivered to frontline teams through a local distribution partnership.
Background
Powered Air-Purifying Respirators were procured to support hospital infection-control programmes during the pandemic response, with units distributed to frontline doctors, nurses, and support staff working in high-risk wards. Distribution in the Philippines was coordinated through Biosite Medical Systems Inc., ICARELIFE's exclusive partner for infection-control equipment in the country.
PAPR Unit Features
Specifications relevant to procurement and infection-control evaluation:
HEPA Filtration
High-efficiency particulate filtration rated for infection-control use.
Extended Shift Design
Lightweight, ergonomic build intended for long-duration ward use.
Battery Runtime
Rechargeable battery designed for extended continuous operation per shift.
Full-Face Visor
Anti-fog coated visor for sustained visibility during procedures.
Distribution Partner: Biosite Medical Systems Inc.
Biosite Medical Systems Inc.
A Philippine distributor of diagnostic instruments, lab supplies, and medical consumables, with operations across Manila, Cebu, and Davao. ISO 9001:2015 certified for medical device trading since 2022, with a track record supplying the Department of Health (DOH) during the COVID-19 response.
Visit Biosite Medical Systems →Regional Track Record
Between 2020 and 2023, PAPR units from this line were supplied to hospital networks across the Philippines and neighbouring Southeast Asian markets for pandemic-response infection control. A number of facilities have continued using the equipment for MDR-TB wards, oncology units, and other high-containment procedures beyond the acute phase of the pandemic — an indicator of sustained procurement value rather than a one-time emergency purchase.
Procurement Considerations
For contractors, distributors, and hospital procurement teams evaluating a PAPR programme:
| Factor | Why It Matters |
|---|---|
| Filter certification | Confirm current HEPA/N95-equivalent test reports, not marketing figures. |
| Battery service life | Match rated runtime to actual shift length, not peak-condition figures. |
| Local support | Confirm the distributor holds spare filters, batteries, and visor seals in-country. |
| Standards alignment | Verify claimed compliance (EN 12941, NIOSH, etc.) against the buyer's regulatory requirement. |
Evaluating PAPR for your hospital or distribution network?
Share your project scope, target standard, and volume — ICARELIFE will confirm current specifications, certification status, and lead times.
